alias :: Bone infection
ICD-11_Code: FA60.0 (Acute osteomyelitis), FA60.1 (Chronic osteomyelitis)
tags :: #Disease, #[[Inflammatory Disease]], #Orthopedics

- #definition  {{c1::Osteomyelitis is an infection of the bone, typically caused by bacteria (most commonly *Staphylococcus aureus*), and can occur acutely or chronically. It involves inflammatory destruction of bone, leading to necrosis, bone loss, and systemic symptoms if untreated.}} #ortho-prof-written
  
  ---
- ### **Etiology**
- **Causative Agents** #ortho-prof-card
	- **Bacterial**:
		- *Staphylococcus aureus* (most common, including MRSA).
		- *Kingella kingae* (children <5 years), *Streptococcus pyogenes*, *Pseudomonas aeruginosa* (IV drug users/diabetics).
		- *Escherichia coli*, *Salmonella* (sickle cell disease), *Coagulase-negative staphylococci*(prosthetic infections).
	- **Fungal**: *Candida*, *Aspergillus* (immunocompromised).
		- **Mycobacterial**: *Mycobacterium tuberculosis* (Pott’s disease).
- #### **Risk Factors**
	- Open fractures, surgical implants, diabetes mellitus, peripheral vascular disease.
	- IV drug use, immunosuppression, sickle cell disease.
- ---
- ### **Epidemiology**
- **Incidence**
	- ~2–5 cases per 10,000 in developed countries; higher in developing nations.
- **Prevalence**
	- More common in children (acute hematogenous) and elderly (chronic, secondary to comorbidities).
	- **Demographics**
		- Age(bimodal)
			- Children: <5 years (long bones affected).
			- Adults: >50 years, Vertebral osteomyelitis, diabetic foot infections.
- **Geographic Distribution**
	- Higher in areas with poor healthcare access, trauma prevalence, or TB-endemic regions.
	  
	  ---
- ### **Pathophysiology**
- **Mechanism of Disease**
	- **Routes of Infection**:
		- **Hematogenous spread**: Metaphysis in children (sluggish blood flow in capillary loops).
		- **Direct inoculation**: Trauma/surgery.
		- **Contiguous spread**: Adjacent soft tissue infection (e.g., diabetic foot ulcers).
	- **Chronic Osteomyelitis**:
		- Inflammatory response → bone ischemia → **sequestrum** (necrotic bone) + **involucrum**(periosteal new bone).
		- **Biofilm formation** on dead bone/implants → antibiotic resistance.
		- **Sinus tracts** → risk of Marjolin’s ulcer (squamous cell carcinoma).
	-
- **Affected Systems/Organs**
	- bones and surrounding soft tissues, systemic sepsis if untreated.
		- **Children**: Long bones (femur, tibia).
		- **Adults**: Vertebrae, pelvis, diabetic foot.
	- **Metaphyseal Predilection**:
		- Vascular loops trap bacteria → abscess formation.
	- **Growth Plate (Physis) Injury**:
		- **Infants**: Transphyseal vessels → direct spread → growth arrest.
		- **Older children**: Physis acts as barrier → deformity rare unless severe.
	- ---
- ### **Clinical Features**
- **Clinical Presentation**
	- #### **Acute Osteomyelitis**
		- **Symptoms**: Fever, localized bone pain, refusal to bear weight (children), pseudoparalysis (infants).
		- **Signs**: Erythema, warmth, tenderness, metaphyseal swelling.
		- **Complications**: Septic arthritis (if metaphysis intra-articular, e.g., hip/shoulder).
	- #### **Chronic Osteomyelitis**
		- **Symptoms**: Insidious pain, recurrent drainage, non-healing ulcers.
		- **Signs**: Sinus tracts, bony deformity, pathologic fractures.
- **Stages or Classification**
	- **Acute** (<2 weeks): Systemic symptoms, rapid progression.
		- Refusal to bear weight, metaphyseal tenderness (e.g., distal femur, proximal tibia).
		  >*Fever with refusal to move in children is acute hematogenous osteomyelitis unless proven otherwise*
		- **Growth plate risk**: Infection can cross physis in infants (<18 months) → growth arrest/deformity (e.g., limb shortening, angular deformity).
		- **Adults**: Vertebral pain (thoracolumbar), may mimic discitis.
	- **Subacute/Chronic** (>2 weeks): Insidious onset, necrotic bone, sinus tracts.
	- **Acute on Chronic**
	- ---
- ### **Diagnosis**
- **Diagnostic Criteria**
	- Clinical suspicion + imaging/lab confirmation.
- **Investigation**
	- **Blood tests**: ↑ESR/CRP, leukocytosis, blood cultures.
	- **Imaging**: X-ray (late changes), MRI (gold standard), bone scan.
		- **X-ray**: Normal first 7–10 days; later shows periosteal elevation/lytic lesions.
			- In Chronic #ortho-prof-card
				- **Sequestrum** (dense necrotic bone fragment).
				- **Involucrum** (periosteal reaction).
				- **Cloaca** (cortical hole draining pus).
		- **MRI**: Gold standard (bone marrow edema, subperiosteal abscess).
			- In chronic
				- Bone marrow edema, sinus tracts, soft tissue abscess
			- **CT**: Best for sequestrum detection (pre-op planning).
		- **Bone scan**: Useful if multifocal (e.g., neonates).
	- **Biopsy**: Culture/histopathology (definitive diagnosis).
- **Ruling Out DD**
  
  | **DD** | **Ruling Out** |
  | ---- | ---- | ---- |
  | Transient synovitis  | No fever, normal CRP |
  | Septic arthritis | Joint aspiration, synovial fluid analysis |
  | Cellulitis | MRI shows no bone involvement |
  | Bone tumor | Biopsy, imaging |
  
  ---
- ### **Management and Treatment**
- **Medical Treatment**
	- IV antibiotics (4–6 weeks): Vancomycin, ceftriaxone, tailored to culture.
		- **Children**:
			- **MSSA**: IV cefazolin/nafcillin (50–100 mg/kg/day).
			- **MRSA/neonates**: Vancomycin + cefotaxime (covers *Group B Strep*).
		- **Adults**: Vancomycin + piperacillin-tazobactam (broad-spectrum).
	- Additional for Chronic
		- Chronic suppression (e.g., oral clindamycin) if unresectable.
- **Surgical Options**
	- Indications
		- Abscess (subperiosteal/soft tissue).
		- No clinical improvement in 48h.
		- Chronic Osteomyelitis
	- Surgical Debridement
		- Debridement, sequestrectomy, bone grafting, antibiotic beads.
		- Remove all necrotic bone/implants.
		- Dead space management: Antibiotic beads, muscle flaps.
- **Lifestyle/Dietary**
	- Optimize diabetes control, smoking cessation, nutrition for wound healing.
- **Follow-up**
	- Monitor ESR/CRP, imaging, clinical response.
	  
	  ---
- ### **Prognosis**
- **With Treatment**
	- 60–90% cure rate; higher in acute cases.
- **Without Treatment** #ortho-prof-card
	- Acute
		- **Septic arthritis** (hip/shoulder if metaphysis intra-articular).
		- **Chronic osteomyelitis** (5–30% if delayed treatment).
		- **Growth arrest** (asymmetric physeal damage → limb deformity).
		- **Pathologic fracture** (lytic weakening of cortex).
	- Chronic
		- Persistent Discharging sinus **Recurrent infection** (due to biofilm/residual necrotic bone).
		- **Pathologic fracture** (from bone weakening).
		- **Squamous cell carcinoma** (Marjolin’s ulcer in sinus tracts).
		- **Amyloidosis** (chronic inflammation).
		  
		  ---
- | Feature | Acute | Chronic |
  | ---- | ---- | ---- |
  | **Onset** | Hours-days | Weeks-months |
  | **Bone Changes** | Periosteal reaction (late) | Sequestrum/involucrum |
  | **Surgery** | Rare (abscess only) | Mandatory (debridement) |
  | **Antibiotics** | 4–6 weeks | 6+ weeks ± suppression |
- **Survival Rates**
	- .> 95% with treatment; mortality <5% in uncomplicated cases.
	  
	  ---
- ### **Prevention**
- **Health Education**: Wound care in diabetics, early infection treatment.
- **Screening**: High-risk populations (diabetics, immunocompromised).
  
  ---
- ### **Patient Education**
- **Resources**: CDC guidelines, wound care clinics.
- **Support Groups**: Diabetes associations, chronic infection networks.
  
  ---
- ### **Recent Research**
- **Advances**: Biofilm-resistant implants, phage therapy trials.
  
  ---
- ### **Key Literature**
- Lew & Waldvogel (2004) on chronic osteomyelitis.
- IDSA Guidelines (2013).
  
  ---
- ### **Guidelines**
- IDSA 2013, NICE (UK) for diabetic foot osteomyelitis.